The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians

The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians

BACKGROUND:The WHO recommends single low-dose primaquine (SLDPQ, 0.25 mg/kg body weight) in falciparum-infected patients to block malaria transmission and contribute to eliminating multidrug resistant Plasmodium falciparum from the Greater Mekong Sub region (GMS). However, the anxiety regarding PQ-i...

Full description

Bibliographic Details
Main Authors:	Dysoley, L, Kim, S, Lopes, S, Khim, N, Bjorges, S, Top, S, Huch, C, Rekol, H, Westercamp, N, Fukuda, M, Hwang, J, Roca-Feltrer, A, Mukaka, M, Menard, D, Taylor, W
Format:	Journal article
Language:	English
Published:	BioMed Central 2019

Similar Items

The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians
by: Lek Dysoley, et al.
Published: (2019-03-01)

Hemolytic dynamics of weekly primaquine antirelapse therapy among Cambodians with acute Plasmodium vivax malaria with or without glucose-6-phosphate dehydrogenase deficiency
by: Taylor, W, et al.
Published: (2019)

Primaquine phosphate (primaquine diphosphate)
by: 982 SIRIM

Primaquine to prevent transmission of falciparum malaria
by: White, N
Published: (2013)

Primaquine to prevent transmission of falciparum malaria.
by: White, N
Published: (2013)

Primaquine to prevent transmission of falciparum malaria.
by: White, N
Published: (2013)

Primaquine phosphate tablets
by: 982 SIRIM

A controlled trial of mass drug administration to interrupt transmission of multi drug resistant falciparum malaria in Cambodian villages
by: Tripura, R, et al.
Published: (2018)

Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: divergent policies and practices in malaria endemic countries
by: Recht, J, et al.
Published: (2018)

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
by: Taylor, WRJ, et al.
Published: (2023)

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency.
by: Walter R J Taylor, et al.
Published: (2023-09-01)

Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials.
by: Guido J H Bastiaens, et al.
Published: (2018-01-01)

Complexity of Infection and Genetic Diversity in Cambodian Plasmodium vivax.
by: Lindsey R Friedrich, et al.
Published: (2016-03-01)

Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers
by: Sasithon Pukrittayakamee, et al.
Published: (2024-02-01)

Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers
by: Pukrittayakamee, S, et al.
Published: (2024)

Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries.
by: Judith Recht, et al.
Published: (2018-04-01)

Novel Cross-Border Approaches to Optimise Identification of Asymptomatic and Artemisinin-Resistant Plasmodium Infection in Mobile Populations Crossing Cambodian Borders.
by: Hannah M Edwards, et al.
Published: (2015-01-01)

Modelling primaquine-induced haemolysis in G6PD deficiency
by: White, N, et al.
Published: (2017)

Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria
by: Taylor, WR, et al.
Published: (2021)

Evaluation of the CareStart™ glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in the field settings and assessment of perceived risk from primaquine at the community level in Cambodia.
by: Bertha Wojnarski, et al.
Published: (2020-01-01)

Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria
by: Mukaka, M, et al.
Published: (2023)

Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, non-inferiority trial
by: Taylor, WR, et al.
Published: (2022)

Oxidative activity of hydroxylated primaquine analogs. Non-toxicity to glucose-6-phosphate dehydrogenase-deficient human red blood cells in vitro.
by: Baird, J, et al.
Published: (1986)

Modelling primaquine-induced haemolysis in G6PD deficiency
by: James Watson, et al.
Published: (2017-02-01)

Plasmepsin II-III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum
by: Bopp, S, et al.
Published: (2018)

Ethics, Economics, and the Use of Primaquine to Reduce Falciparum Malaria Transmission in Asymptomatic Populations
by: Lubell, Y, et al.
Published: (2014)

Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria
by: Walter Robert Taylor, et al.
Published: (2021-09-01)

Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria.
by: Pukrittayakamee, S, et al.
Published: (2004)

Piperaquine resistant Cambodian Plasmodium falciparum clinical isolates: in vitro genotypic and phenotypic characterization
by: Nonlawat Boonyalai, et al.
Published: (2020-07-01)

Socially Isolated Cambodians in the US
by: S. Megan Berthold, et al.
Published: (2018-09-01)

An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia
by: Leang, R, et al.
Published: (2016)

Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria.
by: Fryauff, D, et al.
Published: (1995)

Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malariaResearch in context
by: Mavuto Mukaka, et al.
Published: (2023-10-01)

Erratum to: An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia
by: Leang, R, et al.
Published: (2016)

Plasmepsin II–III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum
by: Selina Bopp, et al.
Published: (2018-05-01)

Evidence of a Mild Mutator Phenotype in Cambodian Plasmodium falciparum Malaria Parasites.
by: Andrew H Lee, et al.
Published: (2016-01-01)

Anti-infectivity efficacy and pharmacokinetics of WHO recommended single low-dose primaquine in children with acute Plasmodium falciparum in Burkina Faso: study protocol
by: Ouédraogo, A, et al.
Published: (2024)

Ethics, economics, and the use of primaquine to reduce falciparum malaria transmission in asymptomatic populations.
by: Yoel Lubell, et al.
Published: (2014-08-01)

Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria
by: Taylor, WRJ, et al.
Published: (2021)

Prevalence of glucose-6-phosphate dehydrogenase deficiency (G6PDd) and clinical implication for safe use of primaquine in malaria-endemic areas of Hainan Province, China
by: Wen Zeng, et al.
Published: (2022-10-01)